blaSHV genes in Klebsiella pneumoniae: Different allele distributions are associated with different promoters within individual isolates

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 1, 2005, Pages 256-263

  Hammond, David S ^a   Schooneveldt, Jacqueline M ^b   Nimmo, Graeme R ^b   Huygens, Flavia ^a   Giffard, Philip M ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIUM ISOLATE; BLA SHV GENE; CODON; DNA POLYMORPHISM; GENE INSERTION; KLEBSIELLA PNEUMONIAE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPLICON;

ALLELES; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE DOSAGE; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 11244336965     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.1.256-263.2005     Document Type: Article

References (19)

1. Blazquez, J., M. I. Morosini, M. C. Negri, and F. Baquero. 2000. Selection of naturally occurring extended-spectrum TEM β-lactamase variants by fluctuating β-lactam pressure. Antimicrob. Agents Chemother. 44:2182-2184.
2. Cantu, C., W. Huang, and T. Palzkill. 1996. Selection and characterization of amino acid substitutions at residues 238-240 of TEM-1 β-lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 271:22538-22545.
3. Essack, S. Y., L. M. Hall, D. G. Pillay, M. L. McFadyen, and D. M. Livermore. 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 45:88-95.
4. Fortineau, N., T. Naas, O. Gaillot, and P. Nordmann. 2001. SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate. J. Antimicrob. Chemother. 47:685-688.
5. Germer, S., M. J. Holland, and R. Higuchi. 2000. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 10:258-266.
6. Howard, C., A. van Daal, G. Kelly, J. Schooneveldt, G. Nimmo, and P. M. Giffard. 2002. Identification and minisequencing-based discrimination of SHV β-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia. Antimicrob. Agents Chemother. 46:659-664.
7. Jacoby, G. A. 1994. Genetics of extended-spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):S2-S11.
8. Kim, J., Y. Kwon, H. Pai, J. W. Kim, and D. T. Cho. 1998. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36:1446-1449.
9. Kim, J., H. S. Shin, S. Y. Seol, and D. T. Cho. 2002. Relationship between blaSHV-12 and blaSHV-2a in Korea. J. Antimicrob. Chemother. 49:261-267.
10. Nuesch-Inderbinen, M. T., H. Hachler, and F. H. Kayser. 1995. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV β-lactamases. Antimicrob. Agents Chemother. 39:1726-1730.
11. Peixe, L. V., J. C. Sousa, J. C. Perez-Diaz, and F. Baquero. 1997. A bla(TEM-1b)-derived TEM-6 beta-lactamase: a case of convergent evolution. Antimicrob. Agents Chemother. 41:1206.
12. Perilli, M., E. Dell'Amico, B. Segatore, M. R. de Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.
13. Pitout, J. D., K. S. Thomson, N. D. Hanson, A. F. Ehrhardt, E. S. Moland, and C. C. Sanders. 1998. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother. 42:1350-1354.
14. Podbielski, A., J. Schonling, B. Melzer, and K. Warnatz. 1991. Molecular cloning and nucleotide sequence of a new plasmid-coded Klebsiella pneumoniae beta-lactamase gene (SHV-2a) responsible for high-level cefotaxime resistance. Zbl. Bakteriol. 275:369-373.
15. Podbielski, A., J. Schonling, B. Melzer, and G. Haase. 1991. Different promoters of SHV-2 and SHV-2a β-lactamase lead to diverse levels of cefotaxime resistance in their bacterial producers. J. Gen. Microbiol. 137:569-578.
16. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press., Cold Spring Harbor, N.Y.
17. Schooneveldt, J. M., G. R. Nimmo, and P. Giffard. 1998. Detection and characterisation of extended spectrum β-lactamases in Klebsiella pneumoniae causing nosocomial infection. Pathology 30:164-168.
18. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
19. Yang, Y., N. Bhachech, P. A. Bradford, B. D. Jett, D. F. Sahm, and K. Bush. 1998. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri. Antimicrob. Agents Chemother. 42:1671-1676.